Market Research Logo

Human Biobanking Equipment - Global Trends, Estimates and Forecasts, 2014-2020 - Industry Overview

Human Biobanking Equipment - Global Trends, Estimates and Forecasts, 2014-2020 - Industry Overview

Biobanks are large collections of biological specimens (tissue and blood samples) with individual specimen information developed under the auspices of public or private initiative for use in biomedical research. Biobanks contain large collections of DNA collected from individuals diagnosed of specific diseases accompanied by detailed health history. Researchers and clinicians investigate biospecimens of specific individuals for indications/diagnosis of disease. These specimens could be used to get DNA, proteins and other molecules that may help in understanding disease progression.

Steps to compile preserve and supply samples for experimentation and study have led to the growth of a fresh dimension in biobanking. Though to organize larger facilities the steps are evident, but huge numbers of DNA, RNA and tissue samples that are present in freezers in personal labs all across the globe is much more than the numbers in the compilations preserved in the national and organizational bio facilities. Having mentioned it would be ridden with problems to use samples collected by different individuals at different locations.

Medical and Genealogical data related to the samples stored in a Biobank are equally important, and Biobanks can be termed as both scientific and social projects. The rapid advances made in genome science of late have made it considerably easier to obtain, save and analyze genetic data.

Thus, large Biobanks can now be analyzed in greater depth, helping to enhance understanding of the biodiversity of the human race. On a large scale, it is vital that Biobanks and related issues are standardized and established across the globe, especially in developing countries.

This is an ongoing process, and there is as yet no particular set of procedures that can be called ―best‖, but there is worldwide focus on improving in this area. The ultimate objective of any Biospecimen resource is to indentify Biomarkers (measurable indicators of disease in a given sample), and this analysis must be done without bias on specimens that have not been compromised in their quality or integrity.

Current advances in genomics technology have made it possible to obtain genetic information from these collections in a faster, cheaper and easier manner for whole genome analysis. Biobanks should be used for investigating the biological biodiversity seen among human populations.

The key to developing personalized medicine and achieving translational research success is ensuring that proven methods are used to extract, store and process high-quality Bio-samples. There has been, and will be, a lot of effort to standardize methods and techniques so that Biobanks across the world can be assured of quality practices.

However, the demands made of modern Biobanks are beginning to outpace the finances available, and so the biorepositories might have to be more selective in what they store and the methods they employ to preserve their samples.

Biobanking is getting recognition a May donor samples and medical data is preserved in bio banks gaining all over the world. The unique innovations are helpful to both the government and to research facilities to analyze and keep record of the bio-sample compilation.


III. INDUSTRY OVERVIEW
A. BIOBANKING - GEOGRAPHICAL DISTRIBUTION IN DETAIL
BIOBANKING IN THE AMERICAS
CANADA
TO ASSESS THE SCALE AND LIMITATIONS OF INDUSTRY ACCESS TO
PUBLICLY-FINANCED BIOBANKS IN CANADA
THE CANADIAN LONGITUDINAL STUDY ON AGING: BIOREPOSITORY FUNCTIONS AND NETWORKS
BRAZIL
OUTCOMES TO GIVE TO CONTRIBUTORS: A DEBATE IN BRAZIL
USA
STATUS ON THE DEVELOPMENT AND GROWTH OF A COMBINED SYSTEM OF REPOSITORIES
AT THE UNIVERSITY OF IOWA
BIOBANKING IN EUROPE
CONSOLIDATION ON PRESENT ADVANTAGES
EUROPEAN BIOBANKS ARE CRUCIAL RESOURCES ASSETS FOR THE DISTRIBUTION OF
INDIVIDUALIZED MEDICINE
COHORTS AS A POTENTIAL INSTRUMENT TO KNOW PERSONALIZED DISTINCTION
ETHICAL, LEGAL AND SOCIAL ISSUES (ELSI)
PRIORITY ISSUES FOR PERSONALIZED MEDICINE WITHIN EUROPE
BIOBANKING AND BIOMOLECULAR RESOURCES INVESTIGATE COMMUNICATIONS
- EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM
FUTURE ENTRY IN TO BIGGER EUROPEAN COHORTS VIA TRANSNATIONAL
BIOBANKING INFRASTRUCTURE BBMRI-LPC
9 YEARS RELATING SWISS BIOBANKS – EN ROUTE TO A SWISS BIOBANKING POLICY
GERMANY
CONSTANT AND MAINTAINANCE AND SUPPORT OF BIOBANK-BASED MEDICAL RESEARCH:
A DECADE OF EXPERIENCE IN GERMANY
AUSTRIA
UNITED KINGDOM
COMBINED EFFECTIVE NETWORK OF BIOBANKS
178. CCB INVENTION OF METHODS FOR DATA SOURCING OF BIOLOGICAL SAMPLES
TO ALL TYPES OF BIOBANKS
179. CCB INVENTION TO BIOBANKS FOR MAINTAINING MINIMUM STANDARDS
180. CCB INVENTION TO BIOBANKS FOR BEST PRACTICE STANDARDS
ITALY
BIOBANKS AND ETHICAL CONCERNS IN ITALY
OTHER EUROPEAN COUNTRIES
STRATEGY DEVELOPMENT FOR EMERGING BIOBANKS ON THE EXAMPLE OF KOSOVO AND ALBANIA
BIOBANKING IN ASIA-PACIFIC
JAPAN
EVALUATION OF ID INTEGRITY WITH ABO BLOOD TYPING-QUESTIONNAIRE TO GENOMIC
DATA IN JAPANESE BIOBANK
ASSESSMENT OF CELL-TYPE COMPOSITION IN PERIPHERAL BLOOD MONONUCLEAR
CELLS ENHANCES VALUE OF OMICS DATA IN BIOBANK RESEARCH
SOUTH KOREA
CURRENT TRENDS IN KOREA GYNECOLOGIC CANCER BANK
EBIOBANKING SYSTEM FOR KOREA GYNECOLOGIC CANCER BANK
CHINA
ACHIEVEMENTS
BIOBANKING FOR THE BORN IN GUANGZHOU COHORT STUDY: AN INNOVATIVE RESOURCE
FOR MATERNAL AND CHILD HEALTH RESEARCH IN CHINA
AIMS
ADVANTAGES
CONSTRUCTION OF SHANGHAI CANCER BIOBANK STAGE FOR RESEARCH
INDIA
OBJECTIVES
GOALS
AREAS
PRINCIPLES
THE AGE BIO-BANKING IN INDIA
TO CREATE A DISEASE-LINKED RELIABLE BIOBANK IN INDIA
MORAL CONCERNS IN BIOBANKING: STEPPING UP THE PROGRAM IN INDIA
BIOBANKING IS A PROMISING PROPOSITION IN INDIA-FACTORS
I. ETHICAL CONCERNS WITH REGARD TO BIOBANKING
PEOPLE‟S PERSPECTIVE TOWARDS BIOBANKING RESEARCH
ACCEPTANCE BY CONTRIBUTORS IN BIOBANKING RESEARCH
CONSENT TYPES
REMOVAL OF CONSENT/OBLITERATION OF BIO-SAMPLES
CHIEF CAUSES FOR PULL OUT
PRIVACY AND SECRECY
181. METHODS TO LINK / DELINK DATA / SAMPLES WITH THEIR IDENTIFIERS
II. ETHICAL ISSUES LINKED TO RESEARCH PROCEDURES
STORAGE OF SAMPLES
DERIVED OR EXTENSIVE USES OF STORED SAMPLES
RELOCATION OF SAMPLES AND INFORMATION
III. CONCLUSION
FIRST BIOBANK BY 2016 IN EASTERN INDIA
AUSTRALIA
AUSTRALIAN PROSTATE CANCER BIO-RESOURCE, 2015
ENHANCING BIO-SAMPLES QUALITY INSIDE THE BANKING SYSTEM: AN AUSTRALIAN OUTLOOK
BIOBANKING IN REST OF WORLD
THE CONSEQUENCES OF MINI-BIOBANK IN HAZARDOUS CLIMATES IN IRAQ
BIODIVERSITY/ENVIRONMENTAL MICROBIAL STOREHOUSE SYSTEM IN EMERGING
NATIONS-SPOTLIGHT ON NIGERIA
THE PROGRESS OF THE NATIONAL BIOBANKING INDUSTRY FOR PRESERVATION
OF SOUTH AFRICAN BIODIVERSITY
QATAR BIOBANK: PUBLIC HEALTH CONCERNS REPORTED
BIOBANKING INITIATIVE IN SAUDI ARABIA: THE CEGMR BIOBANK KNOW-HOW
B. A REVIEW ON BIO “BANKS”
RELEVANCE OF BIOBANKS IN SCIENTIFIC RESEARCH
C. MAJOR PROSPECTS FOR BIOREPOSITORIES IN THE FUTURE
THE KEY IMPACT OF BIOREPOSITORIES IN ITS APPLICATIONS
BIGGEST CHALLENGES AND OPPORTUNITIES IN BIOREPOSITORIES
BIOBANKS WILL BE CHALLENGED BY INCREASING FINANCIAL PRESSURES
BIGGEST OPPORTUNITIES
PRESENT CHALLENGES OF BIOBANKING: BIOETHICAL AND PROPERTY ISSUES
ADDED VALUE OF BIOBANKS FOR HEALTH: AN EVOLUTIONARY PERSPECTIVE
FUTURE CHALLENGES
CONCLUSIONS
D. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/
INNOVATIONS/PRODUCT LAUNCHES/ETC……
CESCA THERAPEUTICS ENTERS INTO COLLABORATIVE AGREEMENT WITH CENTER FOR
IMMUNE CELL THERAPIES AT MEMORIAL SLOAN KETTERING CANCER CENTER
AGILENT TECHNOLOGIES TO ACQUIRE SEAHORSE BIOSCIENCE, INDUSTRY LEADER IN
TOOLS FOR MEASURING CELL METABOLISM
INTERNATIONAL STEM CELL CORPORATION ANNOUNCES NEXT PHASE OF RESEARCH
COLLABORATION WITH ROHTO PHARMACEUTICAL CO., LTD. OF JAPAN
PARTNERS GET $12.3M TO ADVANCE GENOMIC MEDICINE
NEW STUDY DEMONSTRATES ABSENCE OF EXTRACTABLE ORGANIC CONTAMINANTS
IN MICRONIC‟S POLYPROPYLENE SAMPLE STORAGE TUBES
VALEANT PHARMACEUTICALS TO ACQUIRE SYNERGETICS USA
SYSMEX RECEIVES IN-VITRO DIAGNOSTIC APPROVAL FOR MANUFACTURING AND SALES
OF THREE PLATELET AGGREGATION AGONIST REAGENT KITS
AMAG PHARMACEUTICALS COMPLETES ACQUISITION OF CORD BLOOD REGISTRY
BIOTEK SYNERGY™ NEO2 GRANTED CISBIO HTRF® CERTIFICATION
AVITA MEDICAL ANNOUNCES NEW RESEARCH PARTNERSHIP WITH UNIVERSITY OF HUDDERSFIELD
STEMCELL TECHNOLOGIES INC. ENTERS A LICENSING AGREEMENT WITH
IPS ACADEMIA JAPAN, INC. FOR INDUCED PLURIPOTENT STEM CELL RESEARCH TECHNOLOGIES
IMMATICS AND MD ANDERSON ANNOUNCE LAUNCH OF IMMATICS US, INC.,
TO DEVELOP MULTIPLE T-CELL AND TCR-BASED ADOPTIVE CELLULAR THERAPIES
BIO-RAD INTRODUCES THE IH-500, A FULLY AUTOMATED RANDOM ACCESS SYSTEM
FOR BLOOD TYPING AND SCREENING
GROUNDBREAKING CLINICAL TRIAL TO ASSESS USE OF NEWBORN STEM CELLS
IN THE TREATMENT OF PEDIATRIC STROKE
GENOTYPING BEGINS ON NIDA‟S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX,
BIOREALM AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
STEM CELLS - PROMISING OPTIONS FOR ALTERNATIVE MEDICAL THERAPEUTIC APPROACHES
CELGENE HANDED $1 BILLION TO SMALL BIOTECH DEVELOPER JUNO THERAPEUTICS
MEDIMMUNE PARTNERS WITH THE UNIVERSITY OF SHEFFIELD TO GENERATE INNOVATIONS
IN CELL FACTORY ENGINEERING SCIENCE
CYTOX AND AFFYMETRIX FORM STRATEGIC PARTNERSHIP TO DEVELOP AND COMMERCIALIZE
BLOOD-BASED GENETIC ASSAY FOR ALZHEIMER‟S DISEASE RISK ASSESSMENT
GENOTYPING BEGINS ON NIDA‟S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX,
BIOREALM, AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
MOUNT SINAI MEDICAL CENTER SELECTS STEMSOFT CLINIC
INTEGRA LIFESCIENCES COMPLETES ACQUISITION OF TEI BIOSCIENCES AND TEI MEDICAL
BLOODCENTER LAUNCHES GENE DELETION/DUPLICATION ANALYSIS
CRYOPORT PROVIDES CRYOGENIC LOGISTICS SOLUTIONS TO HEMACARE CORPORATION
BIOMATRICA, INC. ANNOUNCES RELEASE OF DNAGARD® SALIVA HT, SALIVA DNA COLLECTION
SERACARE LIFE SCIENCES ANNOUNCES STRATEGIC PARTNERSHIP WITH VIVEBIO TO ENABLE
LAKE SHORE EXHIBITING CRYOGENIC MONITORING AND CONTROL SOLUTIONS AT CEC/ICMC
CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOGLUE® IN JAPAN
DNA GENOTEK INC. RECEIVES CE-IVD MARK FOR ITS OMNIGENE®•GUT MICROBIOME COLLECTION KIT
DEBIOPHARM INTERNATIONAL SA ACQUIRES FIBROTRAP SAMPLE PROCESSING
TECHNOLOGY FROM SPINOMIX
SYSMEX AND LABCORP ANNOUNCE A STRATEGIC COLLABORATION FOR BLOOD-BASED
MOLECULAR TESTING SERVICES AND PRODUCTS TO SUPPORT THE DEVELOPMENT
OF PRECISION MEDICINE IN ONCOLOGY
RENEURON GROUP PLC S RESEARCH COLLABORATION WITH BENITEC BIOPHARMA
STEMCELL TECHNOLOGIES LAUNCHES INNOVATIVE PRODUCTS
TO SUPPORT CAR T CELL RESEARCH
ULTRA LOW BINDING TUBES FOR PROTEOMICS
CALADRIUS BIOSCIENCES, INC. FINALIZES CORPORATE NAME CHANGE FROM NEOSTEM, INC.
STEMGENT, A REPROCELL GROUP COMPANY LAUNCHES A NEW HIGH PERFORMANCE
SELF-REPLICATIVE RNA REPROGRAMMING KIT
TAKARA BIO EUROPE RELEASES AN INNOVATIVE IPS CELL CULTURE MEDIUM FOR
PRE-CLINICAL USE: CELLARTIS® DEF-CS™ XENO-FREE CULTURE MEDIUM GÖTEBORG, SWEDEN
OCTANE AND LONZA ANNOUNCE EXCLUSIVE COLLABORATION TO EVALUATE GROUNDBREAKING
AUTOLOGOUS CELL THERAPY TECHNOLOGY
AXT TO DISTRIBUTE OPENSPECIMEN BIOBANKING SOFTWARE SOLUTION
NIKON AND LONZA FORM COLLABORATION FOR CELL AND GENE THERAPY
MANUFACTURING IN JAPAN
DNA GENOTEK INC. LAUNCHES MICROBIAL DNA SELF-COLLECTION KIT-OMNIGENE®•GUT PRODUCT
OPTIMIZES SAMPLES FOR MICROBIOME ANALYSIS
BIOCISION AND BROOKS AUTOMATION ANNOUNCE INDUSTRY'S FIRST PORTABLE CRYOGENIC
BIOSPECIMEN TRANSPORT SYSTEM WITH INTEGRATED
REAL-TIME TEMPERATURE MONITORING
CRYO-CELL‟S NEW CORD BLOOD PROCESSING METHOD ENABLES PARENTS TO OBTAIN
BETTER CORD BLOOD UNITS FOR THEIR BABIES
AVITA MEDICAL ANNOUNCES ISSUANCE OF A NEW U.S. PATENT FOR RECELL®
TITIAN SOFTWARE EXPANDS OFFERING WITH NEW MOSAIC FREEZER MANAGEMENT
ALLIQUA BIOMEDICAL ANNOUNCES EXPANSION TO ITS EXCLUSIVE LICENSING AGREEMENT
WITH CELGENE CELLULAR THERAPEUTICS
SECURE AUTOMATED CRYOGENIC STORAGE
LONZA, THE WORLD‟S LEADING DEVELOPER AND MANUFACTURER OF CELLS FOR REGENERATIVE
MEDICINE THERAPEUTICS, AND NIKON CORPORATION ANNOUNCED TODAY AN EXCLUSIVE
COLLABORATION IN THE FIELD OF CELL AND GENE THERAPY MANUFACTURING IN JAPAN.
NEOSTEM ANNOUNCES EXPANDED CELL THERAPY MANUFACTURING RELATIONSHIP WITH KITE PHARMA
COMBIMATRIX LAUNCHES BUCCAL SWAB DNA COLLECTION AS ALTERNATIVE TO BLOOD DRAWS
FOR POSTNATAL GENETIC TESTING
NEW ULTRA-LOW TEMPERATURE FREEZER OFFERS OUTSTANDING SUSTAINABILITY
AND SAMPLE PROTECTION
NEOSTEM, INC AND ALLCELLS, LLC TO COLLABORATE WITH MOUNT SINAI AS PART
OF $8.8 MILLION GRANT TO FURTHER STEM CELL RESEARCH
SYSMEX INOSTICS ANNOUNCES AGREEMENT WITH INDIVUTEST TO OFFER BLOOD BASED
MUTATION TESTING
CELGENE TO ACQUIRE QUANTICEL PHARMACEUTICALS
CORD BLOOD REGISTRY® USES BIOLIFE SOLUTIONS CRYOSTOR® CLINICAL GRADE FREEZE MEDIA
IN THE STORAGE OF UMBILICAL CORD TISSUE STEM CELLS
FLORIDA HOSPITAL CANCER INSTITUTE SELECTS STEMSOFT CLINIC
GENMAB ACHIEVES USD 10 MILLION MILESTONES IN DARATUMUMAB COLLABORATION WITH JANSSEN
ALVETEX® 3D CELL CULTURE PLATFORM REACHES NEW HEIGHTS WITH
PROJECT ABOARD THE INTERNATIONAL SPACE STATION (ISS).
LONZA INTRODUCES CYTOSMART™ SYSTEM FOR WALK-AWAY LIVE CELL IMAGING
BROOKS AUTOMATION INTRODUCES BIOSTORE III CRYO AUTOMATED
CRYOGENIC SAMPLE MANAGEMENT SYSTEM
BIOCISION AND BROOKS JOINT DEVELOPMENT PARTNERSHIP TO UNVEIL
NEW CRYOGENIC SAMPLE HANDLING AND TRANSPORT PRODUCT
PAML AND BLOODWORKS NW SIGN LETTER OF INTENT TO COLLABORATE ON INNOVATION
BROOKS AUTOMATION INTRODUCES BIOSTORE III CRYO AUTOMATED
CRYOGENIC SAMPLE MANAGEMENT SYSTEM
BIOTIME‟S CLINICAL GRADE STEM CELLS FROM SUBSIDIARY ES CELL INTERNATIONAL TO BE
USED IN PLANNED CIRM-FUNDED PRECLINICAL STUDIES OF HUNTINGTON‟S DISEASE
BIOTIME LICENSES BECKMAN RESEARCH INSTITUTE OF CITY OF HOPE TO MANUFACTURE
CLINICAL GRADE STEM CELLS
BLOOD CENTER AFFILIATION UNVEILS NEW NAME, EXPANDED OFFERINGS TO HEALTHCARE SYSTEMS
LONZA INTRODUCES CYTOSMART™ SYSTEM FOR WALK-AWAY LIVE CELL IMAGING
FUJIFILM HOLDINGS TO ACQUIRE CELLULAR DYNAMICS INTERNATIONAL, INC.
GENVEC AND THERABIOLOGICS FORM COLLABORATION TO DEVELOP NEURAL STEM CELL MEDIATED
CANCER THERAPIES
CRYO-CELL INTERNATIONAL, INC., CORD BLOOD BANKING LEADER, TAKES SIGNIFICANT OWNERSHIP
STAKE IN CORD BLOOD AMERICA, INC., AND ENCOURAGES CBAI SHAREHOLDERS
TO VOTE AGAINST UPCOMING SHARE AUTHORIZATION PROPOSAL
COMBIMATRIX SELECTS CRYOPORT AS LOGISTICS PARTNER FOR THE DISTRIBUTION
OF ITS NEW GENETIC SCREENING SERVICE
BLUECHIIP TRACKING SOLUTIONS EXECUTING STRATEGIC PRIORITIES IN BIOBANKING
CORDLIFE PARTNERS WITH LEADING NEUROLOGIST ON STUDY IN CHILD AUTISM USING
OWN CORD BLOOD STEM CELLS
LEICA EM CRYO CLEM FEATURES THE WORLD‟S FIRST CRYO CLEM OBJECTIVE
PARTNERSHIP WITH LIVE CELL IMAGING COMPANY
ASTRAZENECA TO COLLABORATE WITH THE HARVARD STEM CELL INSTITUTE IN DIABETES
HANDHELD WIRELESS 1D / 2D CODE READER
BIOLIFE SOLUTIONS CRYOSTOR® CELL FREEZE MEDIA USED IN MAYO CLINIC SAFETY AND FEASIBILITY
STUDY OF UMBILICAL CORD BLOOD-DERIVED CELLS FOR PEDIATRIC CARDIAC REGENERATION
EXPIRATION OF THE OPTION OF TEVA UNDER THE LICENSE AGREEMENT WITH CELLCURE
NEUROSCIENCES
UNIVERSITY OF ILLINOIS AT CHICAGO SELECTS STEMSOFT CLINIC
ESPERITE PIONEERS FIRST TREATMENT WORLDWIDE OF CEREBRAL PALSY USING TWO TYPES
OF STEM CELLS
GREINER BIO-ONE PRESENTS INNOVATIVE CRYO‟S BIOBANKING TUBES
ESI BIO – A DIVISION OF BIOTIME, INC., ANNOUNCES ALLIANCE AGREEMENT WITH PIVOTAL
SCIENTIFIC LTD FOR DISTRIBUTION OF STEM CELL PRODUCTS
PUGET SOUND BLOOD CENTER IS NOW BLOODWORKS NORTHWEST
LABCORP COMPLETES ACQUISITION OF COVANCE
BIOLIFE SOLUTIONS LAUNCHES NEW CELL THAWING MEDIA PRODUCTS IN RESPONSE
TO WORLDWIDE SHORTAGE OF DEXTRAN SOLUTIONS
TIGENIX AND LONZA SIGN AGREEMENT FOR THE MANUFACTURE OF STEM CELL-BASED TREATMENT
OF COMPLEX PERIANAL FISTULAS IN CROHN‟S DISEASE
EPISTEM ANNOUNCES THE SUCCESSFUL EVALUATION OF NEW RNA-AMP™
(RNA-AMPLIFICATION) TECHNOLOGY
STEMGENT, A REPROCELL GROUP COMPANY AND TRANSPOSAGEN BIOPHARMACEUTICALS ENTER
INTO A SERVICE PARTNERSHIP AGREEMENT PROVIDING GENETICALLY ENGINEERED STEM CELLS
TIGENIX AND LONZA SIGN AGREEMENT FOR THE MANUFACTURE OF STEM CELL-BASED TREATMENT
OF COMPLEX PERIANAL FISTULAS IN CROHN‟S DISEASE
INTERNATIONAL STEM CELL CORPORATION ANNOUNCES COMPLETION OF CELL BANK FOR PARKINSON'S
DISEASE CLINICAL TRIAL
CELLULAR DYNAMICS MANUFACTURES CGMP HLA “SUPERDONOR” STEM CELL LINES TO ENABLE
CELL THERAPY WITH GENETIC MATCHING
VITRO BIOPHARMA ANNOUNCES ADVANCES IN CLINICAL APPLICATION OF STEM CELL THERAPY
FOR NEUROLOGICAL CONDITIONS
NEW HEALTHY AGEING BIOBANK MILESTONE
ALLIQUA BIOMEDICAL, INC. TO ACQUIRE CELLERATION, INC.
AGILENT TECHNOLOGIES INTRODUCES ONESEQ TO STREAMLINE CYTOGENETIC RESEARCH
CANCERCARE MANITOBA SELECTS STEMSOFT LAB
ALLIQUA BIOMEDICAL ANNOUNCES GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
VALEANT AND ASTRAZENECA TO PARTNER ON BRODALUMAB
HARVARD BIOSCIENCE ACQUIRES ALL OPERATIONS OF HEKA ELECTRONIK
BROOKS AUTOMATION ANNOUNCES COLLABORATION AGREEMENT WITH CHART INDUSTRIES
AVITA MEDICAL ANNOUNCES FIRST PATIENT ENROLLMENT IN US PIVOTAL STUDY OF RECELL®
FOR THE TREATMENT OF BURNS
NEOSTEM RECEIVES DRUG MANUFACTURE LICENSE FOR IRVINE FACILITY
NEOSTEM AND INVETECH ANNOUNCE AGREEMENT TO DEVELOP CLOSED PROCESSING SYSTEM
FOR CELL THERAPY MANUFACTURING
CORD BLOOD REGISTRY AND CELLULAR DYNAMICS INTERNATIONAL ANNOUNCE COLLABORATION
TO REPROGRAM NEWBORN STEM CELLS INTO INDUCED PLURIPOTENT STEM CELLS
CORD BLOOD REGISTRY AND CHINA CORD BLOOD CORPORATION ENTER INTO STRATEGIC COLLABORATION
LIFECELL CORPORATION AND NOVADAQ TECHNOLOGIES AGREE TO EARLY TRANSITION OF SPY ELITE® INTRAOPERATIVEPERFUSION ASSESSMENT SYSTEM BUSINESS BACK TO NOVADAQ.
FDA CLEARS MAYO CLINIC FOR MANUFACTURE OF NUROWN AND PARTICIPATION IN BRAINSTORM‟S PHASE 2 ALS TRIAL
BEAUMONT, BOTSFORD, OAKWOOD REACH DEFINITIVE AGREEMENT TO CREATE NEW, NOT-FOR-PROFIT HEALTH ORGANIZATION
THERMO FISHER SCIENTIFIC COMPLETES ACQUISITION OF LIFE TECHNOLOGIES CORPORATION
BIOPTA ANNOUNCES LAUNCH OF INDUSTRY‟S FIRST CATALOGUE OF IN VITRO HUMAN TISSUE ASSAYS
THERMO FISHER SCIENTIFIC REACHES AGREEMENT TO SELL ITS CELL CULTURE,
GENE MODULATION AND MAGNETIC BEADS BUSINESSES TO GE HEALTHCARE
BIOMATRICA AND SIGMA-ALDRICH SIGN DISTRIBUTION AGREEMENT
ATHERSYS ANNOUNCES NEW PATENTS IN JAPAN FOR STEM CELL AND REGENERATIVE
MEDICINE TECHNOLOGY
CELL THERAPY'S HEART TISSUE REGENERATION HOPE
CELLULAR DYNAMICS SIGNS AGREEMENT WITH NESTLE INSTITUTE OF HEALTH SCIENCES
TO SUPPLY ICELL® AND MYCELL® PRODUCTS FOR NUTRITIONAL RESEARCH
LIFECELL CORPORATION ACQUIRES ADVANCED ADIPOSE TISSUE INJECTOR
COMBIMATRIX ANNOUNCES CONTRACT WITH GALAXY HEALTH NETWORK
COMBIMATRIX ANNOUNCES PARTNERSHIP WITH PROPATH TO PROVIDE
PRODUCTS OF CONCEPTION TESTING
STEMSOFT SOFTWARE INC. AND JAF CONSULTING, INC. ANNOUNCE COLLABORATIVE PARTNERSHIP
THERMO FISHER SCIENTIFIC REACHES AGREEMENT TO SELL ITS CELL CULTURE,
GENE MODULATION AND MAGNETIC BEADS BUSINESSES TO GE HEALTHCARE
NEW DMSO-RESISTANT 1536 WELL STORAGE PLATE
BMG LABTECH AND INVIVOSCIENCES, INC. INITIATE MARKET COLLABORATION TO
ACCELERATE DRUG DISCOVERY IN ENGINEERED 3D TISSUES
LOW PROFILE SCREW CAPS DESIGNED IN CONJUNCTION WITH THE HANNOVER
UNIFIED BIOBANK LAUNCHED BY MICRONIC
QUEENSLAND NODE OF APCB GAIN ACCESS TO UNIQUE SAMPLES
THERMO FISHER SCIENTIFIC BRINGS SEVERAL INNOVATIONS IN BIOPROCESSING
TECHNOLOGIES AND SYSTEMS
E. MARKET TRENDS
GROUNDBREAKING TECHNOLOGY COLLABORATION TO OPTIMIZE MEDICAL RESEARCH
FIRST 300 CELL LINES TO SUPPORT AUTISM, HEART, LIVER, LUNG AND EYE DISEASE RESEARCH
TOWARDS „ENGAGEMENT 2.0‟: INSIGHTS FROM A STUDY OF DYNAMIC CONSENT
WITH BIOBANK PARTICIPANTS
FINDING BIOMARKERS FOR EARLY LUNG CANCER DIAGNOSIS
BIOBANKING VIABLE IMMUNE CELLS - TRANSPORTATION MATTERS!
CANCER BIOBANK INFORMS FUTURE TREATMENT
WORLD‟S FIRST T CELL-QUALIFIED SERUM REPLACEMENT NOW AVAILABLE
BIOBANKING: A VITAL ASSET FOR BELGIUM SCIENTIFIC EXCELLENCE
PLASMA BIOBANKING: MAXIMIZING PATIENT SAMPLES
BRIDGING „BIOBANKING‟ AND BIOMEDICAL RESEARCH ACROSS EUROPE AND AFRICA:
„B3AFRICA‟ LAUNCHED IN CAPE TOWN
FINDING THE BEST WAY TO PROCESS GUT MICROBIOME SAMPLES
INNOVATION IN BIOBANKING: PUSHING THE BOUNDARIES
NEW RESEARCH TOOL TRACKS REAL-TIME DNA-PROTEIN BINDING IN CELLS
SEOULIN BIOSCIENCE TO DISTRIBUTE CELLULAR DYNAMICS‟ PRODUCTS IN KOREA
CRYOGENIC STORAGE SOLUTION AVAILABLE IN EUROPE
A NEXT-GEN BIOBANK THAT‟S BASED ON THE CLOUD
HEALTH RESEARCH GROUP MAKES RECOMMENDATIONS ON EU DATA PROTECTION REFORMS
GENOTYPING BEGINS ON NIDA‟S BIOREPOSITORY OF OVER 50,000 SAMPLES – AFFYMETRIX, BIOREALM,
AND RUCDR INFINITE BIOLOGICS TEAM UP TO HELP STUDY THE GENETICS OF ADDICTION
REG-GALAPAGOS LICENSES ORGANOID TECHNOLOGY FROM THE HUB FOUNDATION FOR
USE IN CYSTIC FIBROSIS AND IBD RESEARCH
CCFA LAUNCHES DEVELOPMENT OF WORLD‟S LARGEST RESEARCH DATABASE FOR CROHN‟S
DISEASE AND ULCERATIVE COLITIS
THE JOINT VENTURE OF SYNOVIAL TISSUE CRYOPRESERVATION
ANTIFREEZE POLYMER PROTECTS CELLS AS THEY THAW
AUSTRALIA‟S FIRST COMPREHENSIVE SKIN CANCER TISSUE BANK
AWARENESS OF THE PROCURE BIOBANK
BIOSAMPLES AND CRYOPRESERVATION: WHAT TUBE SHOULD I USE?
IBBL TEACHES THE INS AND OUTS OF BIOBANKING
NHLBI NEXT GEN CONSORTIUM PARTNERS WITH WICELL TO DISTRIBUTE OVER
1,500 WELL-CHARACTERIZED, NOVEL CELL LINES FOR USE IN DISEASE RESEARCH
AUTOMATED PBMC ISOLATION FOR BIOBANKING WITH TECAN‟S FREEDOM EVO®
BIOTEK EXPANDS IN THE UNITED KINGDOM
ECACC AND DS PHARMA – 10 YEARS SUPPORTING CELL CULTURE SCIENCE IN JAPAN
DRIED BLOOD SPOTS: NEW APPLICATIONS FOR BIOBANKING?
MULTICARE, BLOODWORKS NW EXPAND SOUTH SOUND CORD BLOOD COLLECTION
NEW ULTRA-LOW TEMPERATURE FREEZER OFFERS OUTSTANDING SUSTAINABILITY
AND SAMPLE PROTECTION
BIOBANKING FOR GLOBAL PROSTATE CANCER RESEARCH COLLABORATION
THE UK HAS JOINED THE BIOBANKING AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE
- EUROPEAN RESEARCH INFRASTRUCTURE CONSORTIUM (BBMR-ERIC) AT ITS GENERAL ASSEMBLY
BIOBANKING COLLABORATION FOR LUNG CANCER RESEARCH
LONG-TERM BIOBANKING: HOW LONG CAN YOU HOLD SAMPLES?
CONTROLLING SAMPLE EXPOSURE TO TEMPERATURE VARIABILITY
THL OBTAINED PERMISSION TO TRANSFER OLD SAMPLE COLLECTIONS TO THL BIOBANK
CHOOSING COLLECTION KITS VERSUS BULK SUPPLIES
FUTURE OF BIOBANKING AND TRANSLATIONAL RESEARCH IN CHINA
UW TO SELL PATIENT TISSUE SAMPLES TO SUPPORT RESEARCH
MSC FROM CORD TISSUE USED TO TREAT GRAFT-VERSUS-HOST DISEASE
FIRST PATIENT SUCCESSFULLY TRANSPLANTED WITH CRYOPRESERVED (FROZEN) NICORD®
IN GAMIDA CELL‟S ONGOING PHASE I/II CLINICAL TRIAL FOR BLOOD CANCERS
STORE FOR 20 MILLION BIO-SAMPLES OPENS IN MILTON KEYNES
PASS THE TISSUE: UA CREATES BIO REPOSITORY TO SHARE WITH COMPETING UNIVERSITIES
COLD STORAGE: DEEP-FREEZE UNIT IS VITAL TO OKLAHOMA MEDICAL RESEARCH FOUNDATION'S WORK
NEW EUROPEAN STORAGE BANK FOR STEM CELL STUDIES COMING TO BABRAHAM RESEARCH CAMPUS
STEM CELLS: FIRST THERAPY APPROVED BY EU
NATIONAL BIOBANK SYMPOSIUM STRENGTHENS COOPERATION IN THE BIOBANK RESEARCH
FROM DRIED COD TO TISSUE SAMPLE PRESERVATION
HEMATOLOGIC CANCERS: UMBILICAL CORD TRANSPLANTATION
NEW METHOD TO MULTIPLY STEM CELLS MAKES CORD BLOOD EVEN MORE VALUABLE
BIOHEART ANNOUNCES PARTNERSHIP IN COLOMBIA
SURVEY OF BIOBANKS 2014 IN AUSTRALIA
BIOBANKS COOPERATION WILL BRING OPPORTUNITIES TO THE INDIVIDUAL TREATMENT
OF PATIENTS PUBLISHED
LUXEMBOURG‟S BIOBANK COLLABORATES WITH US NATIONAL CANCER INSTITUTE
IBBL IS CENTRAL BIOBANK FOR A NEW EUROPEAN CANCER RESEARCH PROGRAMME
CORD BLOOD CURE FOR AUTISM
RESEARCH THAT EXPLORES THE USE OF UMBILICAL CORD BLOOD CELLS
NEW DISTRIBUTION PARTNER FOR BIOTISSUE IN GERMANY, AUSTRIA AND SWITZERLAND
RESEARCH THAT EXPLORES THE USE OF UMBILICAL CORD BLOOD CELLS
TWO NEW CHORDOMA CELL LINES DEVELOPED, HEADING TO REPOSITORY
VALLEY MEDICAL CENTER AND PSBC PARTNER IN CORD BLOOD PROGRAM
COULD PREMATURE BABIES BENEFIT FROM THEIR OWN CORD BLOOD STEM CELLS
NCI BIOBANK SURVEY
THL BIOBANK IN FINLAND RECEIVES LICENSE TO OPERATE
FAMILYCORD INTRODUCES FAMILYCORD VENEZUELA
PLASTICELL SIGNS DEAL WITH JCR PHARMACEUTICALS TO USE COMBICULT ®
STEM CELL TECHNOLOGY IN JAPAN
EBISC – THE FIRST EUROPEAN BANK FOR INDUCED PLURIPOTENT STEM CELLS
SUCCESSFUL RELEASE OF SAMPLE TO TREAT SCID
WICELL EXPANDS OFFERINGS FOR RESEARCHING HUMAN DISEASE WITH CELL LINES DESIGNED BY LIFE
TECHNOLOGIES FOR FLUORESCENT PROTEIN EXPRESSION
BIOBANKING FROM THE PATIENT PERSPECTIVE
THE FUTURE OF BIOBANKING
THE CHALLENGE: RECRUIT 500,000 PARTICIPANTS
2015 EU DATA PROTECTION REGULATION – IMPACT ON RESEARCH UPDATES
LATEST CRYO-CELL INTERNATIONAL DEVELOPMENTS
CORD BLOOD STEM CELLS CAN TREAT OVER 80 LIFE-THREATENING DISEASES
ENRICHING DATASETS THROUGH NORWEGIAN BIOBANK DATA FROM LIFANDIS AS AND
THE IMS PYGARGUS METHODOLOGY
IRVINE SCIENTIFIC INTRODUCES DMSO-FREE, CHEMICALLY-DEFINED CRYOPRESERVATION
SOLUTION FOR MESENCHYMAL STEM CELLS
182. WORLDWIDE KEY PLAYERS INTO HUMAN BIOBANKING INDUSTRY THAT PROJECT
IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
F. KEY COMPANY PROFILES
NORTH AMERICA
VERICEL CORPORATION
ACORDA THERAPEUTICS, INC.
ALPHA CORD, INC.
AFFYMETRIX, INC.
CELLERANT THERAPEUTICS, INC.
CRYO-CELL INTERNATIONAL, INC.
MESOBLAST, INC.
ATGC LABS
AUTOGEN, INC.
BARBER NICHOLS
BECKMAN COULTER, INC.
BIOCISION
U.S. STEM CELL, INC.
BIOLIFE SOLUTIONS, INC.
BIOLOGICAL SPECIMEN INVENTORY SYSTEM
BIOMATRICA, INC.
BIOSTORAGE, LLC
CTI BIOPHARMA CORP.
CHART INDUSTRIES, INC.
CHARTER MEDICAL, LTD.
CORCELL, INC.
CORD BLOOD REGISTRY
CORE DYNAMICS (USA), INC.
CRYOLIFE, INC.
CRYOMAGNETICS, INC.
CRYOPLUS, INC.
CRYOXTRACT
CUSTOM BIOGENIC SYSTEMS
DATAWORKS DEVELOPMENT, INC.
DNA GENOTEK, INC.
EPL ARCHIEVES, INC.
GENZYME CORP.
GILEAD SCIENCES, INC.
HAMILTON STORAGE TECHNOLOGIES
LABVANTAGE SOLUTIONS, INC
LABWARE, INC.
LIFENET HEALTH
CALADRIUS BIOSCIENCES, INC.
EPPENDORF, INC.
NOVARE BIOLOGISTICS
ORIGEN BIOMEDICAL, INC.
OSIRIS THERAPEUTICS, INC.
PACIFIC BIO-MATERIAL MANAGEMENT, INC.
PROMEDDX, LLC
PROVIA LABORATORIES, LLC
QIAGEN NV
RAND CORPORATION
RURO
SERACARE LIFE SCIENCES
SCIENTIFIC INSTRUMENTS, INC.
SP SCIENTIFIC
SPECTROCELL, INC.
ABBOTT LABORATORIES
STEELGATE, INC.
TRILLIUM THERAPEUTICS, INC.
STEM CELLS, INC.
STEMCELL TECHNOLOGIES, INC.
LIFELINE® CELL TECHNOLOGY
THERMO FISHER SCIENTIFIC, INC.
CESCA THERAPEUTICS, INC.
TRANS-HIT BIOMARKERS, INC.
VAISALA, INC.
VIACORD
VITAL THERAPIES, INC.
WHEATON SCIENCE PRODUCTS, INC.
EUROPE
PANASONIC BIOMEDICAL B.V
EPISTEM LTD.
AQIX
B & C GROUP
BBMRI
LIFEGENE
BIOBANK IRELAND TRUST
ASIA-PACIFIC
COLE PARMER INSTRUMENT, CO.
CORDLIFE PTE., LTD.
CRYOCORD SDN. BHD.
CRYOLOGIC PTY. LTD.
GENESEARCH
OCIMUM BIOSOLUTIONS
RELIANCE LIFE SCIENCES
CHINA CORD BLOOD CORPORATION
REST OF WORLD
BABYCELL EGYPT
GAMIDA CELL LTD
IV. INDUSTRY COMPANY DATABASE
V. APPENDIX
A. RESEARCH FOCUS
B. ABOUT AXIS RESEARCH MIND
C. DISCLAIMER
D. FEEDBACK

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report